PFE
31
-27
XYL
25
-35
XRAY
31
-13
V
50
-26
AVB
37
7
FTI
63
3
PLD
32
-19
GRMN
37
-8
PRGO
39
-19
EQIX
59
6
DHI
32
-3
PPL
54
-26
CVS
33
-2
UHS
52
-16
FLS
46
-4
URI
42
-26
AXP
69
-2
AMG
71
-3
RL
68
-15
NWSA
73
3
PFE
31
-27
XYL
25
-35
XRAY
31
-13
V
50
-26
AVB
37
7
FTI
63
3
PLD
32
-19
GRMN
37
-8
PRGO
39
-19
EQIX
59
6
DHI
32
-3
PPL
54
-26
CVS
33
-2
UHS
52
-16
FLS
46
-4
URI
42
-26
AXP
69
-2
AMG
71
-3
RL
68
-15
NWSA
73
3
Financhill
Back

Amplify BlackSwan Growth & Treasury Core ETF Vs. Rhythm Pharmaceuticals, Inc. Sector Stock Comparison

Sell
49

SWAN
Amplify BlackSwan Growth & Treasury Core ETF

Last Price:
$32.62
Seasonality Move:
-1.09%
Sell
50

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$111.57
Seasonality Move:
-13.08%
Sell
49
Amplify BlackSwan Growth & Treasury Core ETF (SWAN) is a Sell

Is Amplify BlackSwan Growth & Treasury Core ETF a Buy, Sell or Hold?

  • The current Amplify BlackSwan Growth & Treasury Core ETF [SWAN] share price is $32.32. The Score for SWAN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SWAN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SWAN Stock Price Chart

What is Amplify BlackSwan Growth & Treasury Core ETF's stock price today?

  • The Amplify BlackSwan Growth & Treasury Core ETF share price today is $32.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWAN is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

SWAN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.58 Buy
Relative Strength Index (14 RSI): 41.83 Sell
Chaikin Money Flow: -8774 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.28 - 32.92) Sell
Bollinger Bands (100): (31.48 - 32.8) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.92 Buy
Relative Strength Index (14 RSI): 57.01 Buy
Chaikin Money Flow: -264527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.99 - 110.55) Buy
Bollinger Bands (100): (94.91 - 108.39) Buy

SWAN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.68 Sell
20-day SMA: 32.65 Sell
50-day SMA: 32.61 Sell
200-day SMA: 30.76 Buy
8-day EMA: 7.18 Buy
20-day EMA: 3.08 Buy
50-day EMA: 1.27 Buy
200-day EMA: 0.32 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.83 Buy
20-day SMA: 106.87 Buy
50-day SMA: 105.94 Buy
200-day SMA: 82.62 Buy
8-day EMA: 24.86 Buy
20-day EMA: 10.65 Buy
50-day EMA: 4.39 Buy
200-day EMA: 1.11 Buy

Amplify BlackSwan Growth & Treasury Core ETF Earnings Growth & SWAN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

Amplify BlackSwan Growth & Treasury Core ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):